GenOway Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 124

Employees

  • Stock Symbol
  • ALGEN

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $4.28
  • (As of Friday Closing)

GenOway General Information

Description

Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmaceutical industries and research industries.

Contact Information

Website
www.genoway.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
PAR
Primary Office
  • 31 Rue Saint Jean de Dieu
  • 69007 Lyon
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenOway Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.28 $4.39 $3.75 - $4.71 7.73K

GenOway Financials Summary

In Thousands,
USD 		TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 39,042 47,707 30,405
Revenue 19,489 17,930 16,575 12,557
EBITDA 4,358 3,435 1,863 1,091
Net Income 1,669 818 (381) (783)
Total Assets 35,470 35,307 36,978 33,909
Total Debt 8,839 9,701 12,257 13,241
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GenOway Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Genoway SA specializes in genetic designs to serve genetically modified (GM) mice, rat and cell lines for the biopharmac
Biotechnology
Lyon, France
124 As of 2023
000.00
00.00 0000-00-00
000000000 000.00

0000 0

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000000
Hyderabad, India
000 As of 0000
00000000

000000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
0000000000000
Tokyo, Japan
000 As of 0000
0000
00.00 0000-00-00
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenOway Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vivo Bio Tech Corporation Hyderabad, India 000 00000000
0000000000 Corporation Tokyo, Japan 000 0000 00000000 0000
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 00000 000000000 00000
000000 00000000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
You’re viewing 5 of 23 competitors. Get the full list »

GenOway Patents

  • 41

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GenOway Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1814998-B1 Animal models comprising at least one conditional ko and one conditional ki Inactive 08-Nov-2004 00000000000
EP-1814998-A2 Animal models comprising at least one conditional ko and one conditional ki Active 08-Nov-2004 00000000000
FR-2877676-B1 Animals models comprising at least one ko and a conditional ki Inactive 08-Nov-2004 00000000000
FR-2877675-B1 Expression of heterologous genes specifically in certain transgenic animal tissues Inactive 08-Nov-2004 00000000000
FR-2877676-A1 Animals models comprising at least one ko and a conditional ki Active 08-Nov-2004 C12N15/8509 0
To view GenOway’s complete patent history, request access »

GenOway Executive Team (2)

Name Title Board Seat Contact Info
Alexandre Fraichard Ph.D Founder, General Manager, Chief Executive Officer, Chief Operating Officer & Board Member
Benjamin BRUNEAU Chief Financial Officer
To view GenOway’s complete executive team members history, request access »

GenOway Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenOway Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenOway‘s full profile, request access.

Request a free trial

GenOway Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Axenis 06-Sep-2018 0000000000 Pharmaceuticals 000000000
Murinus 12-Jan-2005 Merger/Acquisition Other Commercial Services 000000000
To view GenOway’s complete acquisitions history, request access »